-
Joan Costa-Font, PhD
Professor, Department of Health Policy
London School of Economics and Political Science
Joan Costa-Font, PhD is a Professor at the London School of Economics and Political Science (LSE) in London, England. Dr. Costa-Font's areas of specialization include healthy aging and caregiving and health behavior and inequality. Dr. Costa-Font's other research interests relate to understanding health care governance, behavioral political economy and health policy design and evaluation.
-
Tewodros "Teddy" Eguale, PhD
Professor, Department of Pharmaceutical Business & Administrative Sciences
Massachusetts College of Pharmacy and Health Sciences
Tewodros Eguale, MD, MS, PhD is a Professor of Epidemiology and Biostatistics at Massachusetts College of Pharmacy and Health Sciences in Boston, Massachusetts. Dr. Eguale’s research encompasses improving population-based health outcomes, largely from the perspective of studying off-label use of pharmaceuticals in clinical practice, safety, and effectiveness compared with FDA approved pharmaceuticals. Dr. Eguale’s other areas of research include primary drug non-adherence, validation of machine-learning algorithms through structured medical chart review, and evaluation of vulnerability of electronic health record systems leading to medication errors and improving pharmaco-surveillance by active surveillance with electronic documentation of adverse drug reaction at the point of care.
-
Jaime Espín, PhD
Professor, Andalusian School of Public Health
University of Granada
Jaime Espín, PhD is a health economist working as Professor at the Andalusian School of Public Health, Spain. Dr. Espín research focuses on European and Latin American pharmaceutical policies, drug pricing, including reference pricing, and reimbursement. Dr. Espín other research interests include the impact of drug pricing policies on patient access to pharmaceuticals and associated health outcomes and methodological tools and practices related with the implementation and applications of health technology assessment and economic evaluation.
-
Anna Kiyomi, PhD
Assistant Professor, Department of Drug Safety and Risk Management
Tokyo University of Pharmacy and Life Sciences
Anna’s research focuses on clinical pharmacology, drug safety, pharmacoepidemiology and medication outcomes. Other areas of interest include the identification of the incidence rate and risk factors for side effect with anticancer drugs, interventional studies for personalized medicine among breast cancer patients, and the prevention of adverse effects related to chemotherapy
-
Joel Lexchin, MD
Professor Emeritus, School of Health Policy and Management
York University
Joel Lexchin, MD is a Professor Emeritus at the School of Health Policy and Management, York University and an Associate Professor in the Department of Family and Community Medicine at the University of Toronto in Toronto, Canada. Dr. Lexchin research focuses on the cost and prices of pharmaceuticals in Canada, public and private drug formularies, and overall Health Canada’s regulatory decisions
